← FDA Drug Approvals (Drugs@FDA)
KETOROLAC TROMETHAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ATNAHS PHARMA US · Approved 2022-10-21
Drug application
- FDA Application #
ANDA216407- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- KETOROLAC TROMETHAMINE
- Generic name
- KETOROLAC TROMETHAMINE
- Active ingredients
- KETOROLAC TROMETHAMINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ATNAHS PHARMA US
- Manufacturer
- ATNAHS PHARMA US LIMITED
- First approval
- 2022-10-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown